K22.71 Barrett's esophagus with dysplasia

Name of the Condition

• Barrett's esophagus with dysplasia

Summary

Barrett's esophagus with dysplasia is a precancerous condition where the normal lining of the esophagus is replaced by intestinal-type tissue (intestinal metaplasia) and shows abnormal cellular changes (dysplasia). This condition is associated with chronic gastroesophageal reflux disease (GERD) and increases the risk of developing esophageal adenocarcinoma. Diagnosis typically involves endoscopic evaluation with biopsy to assess dysplasia grade.

Causes

The primary cause is chronic exposure of the esophageal lining to stomach acid and bile, most commonly due to GERD. Long-term acid reflux damages the esophageal epithelium, leading to intestinal metaplasia. Dysplasia arises when these abnormal cells undergo further genetic changes, often driven by persistent inflammation and acid exposure.

Risk Factors

• Chronic gastroesophageal reflux disease (GERD)
• Obesity, particularly abdominal obesity
• Male gender
• Age (more common in adults over 50)
• Tobacco use
• Family history of Barrett's esophagus or esophageal cancer

Symptoms

• Chronic heartburn or acid reflux
• Difficulty swallowing (dysphagia)
• Chest pain unrelated to heartburn
• Regurgitation of food or liquid
• Unexplained weight loss (in advanced cases)

Diagnosis

Diagnosis requires an upper endoscopy with targeted biopsies to confirm intestinal metaplasia and assess dysplasia grade. Biopsies are graded as negative for dysplasia, indefinite for dysplasia, low-grade dysplasia, or high-grade dysplasia. Additional tests, such as chromoendoscopy or confocal laser endomicroscopy, may aid in detecting dysplastic areas.

Treatment Options

• Endoscopic therapies (e.g., radiofrequency ablation, endoscopic mucosal resection) for dysplasia
• Proton pump inhibitors to reduce acid reflux
• Surveillance endoscopies to monitor for progression
• Surgical intervention (e.g., esophagectomy) for high-grade dysplasia or early cancer

Prognosis and Follow-Up

Prognosis depends on dysplasia grade and response to treatment. Low-grade dysplasia may regress with acid suppression and surveillance, while high-grade dysplasia carries a higher risk of progression to cancer. Regular endoscopic follow-up is critical to detect changes early.

Complications

• Progression to esophageal adenocarcinoma
• Strictures or narrowing of the esophagus
• Bleeding from esophageal lesions
• Obstruction or difficulty swallowing

Lifestyle & Prevention

• Manage GERD with lifestyle modifications (e.g., diet, weight loss)
• Avoid tobacco and excessive alcohol use
• Elevate the head of the bed to reduce reflux
• Follow prescribed acid-suppressing medications

When to Seek Professional Help

Seek immediate care for severe chest pain, difficulty swallowing, unexplained weight loss, or signs of bleeding (e.g., vomiting blood, black stools). Regular follow-up is essential for those with a history of Barrett's esophagus.

Tips for Medical Coders

Document the dysplasia grade (e.g., low-grade, high-grade) and any associated procedures (e.g., endoscopic therapy) to support coding accuracy. Ensure clinical documentation specifies the presence and grade of dysplasia, as this impacts code assignment and reflects disease severity.